Study of Safety, Tolerability, and Anti-Viral Effect of Locteron Compared to PEG-Intron in Patients With Chronic Hepatitis C
Clinical trial NCT00593151 · COMPLETED
Trial details
- NCT number
- NCT00593151
- Sponsor
- Biolex Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-01
- Primary completion
- 2008-12-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.